Analysis originally distributed on August 30, 2017 By: Michael Vodicka of Cannabis Stock Trades
Opioid abuse has quickly grown into a major global epidemic.
While opioids can be great for pain relief, the down side is that they are highly addictive. Recent data shows that opioid abuse and addiction is killing tens of thousands of people every year in just the United States.
Overdose deaths caused by prescription opioids have quadrupled since 1999. From 1999 to 2015, more than 183,000 people have died in the U.S. from overdoses related to prescription opioids.
This is an alarming trend that has both patients and health care professionals asking - are we capable of providing a better alternative?
According to a young biotech located Australia the answer is yes - and the solution comes in the form of cannabis.
If this young cannabis biotech is correct, not only will patients benefit, early shareholders will be rewarded with huge gains.
Let's take a look. Continue reading "Australian Cannabis Biotech Up 271%"
Analysis originally distributed on April 26, 2017 By: Michael Vodicka of Cannabis Stock Trades
Israel has long been a powerhouse in medical innovation.
The tiny country of 8.5 million has made some of the most important contributions to the global medical field in the last 50 years.
Today, Israel is unleashing its innovative medical industry on the cannabis industry.
According to a report from Reuters, there are more than 120 clinical cannabis trials in Israel at the beginning of 2017, more than any other country.
Foreign countries and firms are eager to license Israel cannabis medical patents. In the last year outside countries and companies have invested $100 million to license Israeli medical cannabis patents.
That number is expected to grow to more than $1 billion in the next two years - an increase of 1,000%.
Israel is winning in the global cannabis industry for two reasons. Continue reading "This Little-Known Israeli Biotech Is Up 468% In 2017"
Analysis originally distributed on November 1, 2016 By: Michael Vodicka of Cannabis Stock Trades
Cannabis stocks are red hot.
The MJIC North American Marijuana Stock Index is up more than 130% in the last six weeks. Take a look below.
In the meantime, the S&P 500 is up 5% on the year.
I’m not trying to dis the S&P 500. These are the best companies in the world and that’s actually a respectable performance.
But for investors looking for growth, the question has been answered. Yes. Cannabis stocks are the place to be in 2016. Continue reading "The North American Marijuana Stock Index Is Up More Than 130% In The Last Six Weeks"
By: Andy Obermueller of Street Authority
Let me start off by saying that today's essay is not for everyone. But as Chief Investment Strategist for Game-Changing Stocks, it's my job to bring readers the best aggressive growth investing opportunities the market has to offer.
If it just so happens to come from an industry that some find morally objectionable, then so be it.
But I received a question from a subscriber the other day that I know many of our readers have been wondering about: Should I invest in marijuana stocks? If so, which ones should I be looking at? Continue reading "Should You Invest In Marijuana Stocks?"
Article source: http://www.streetauthority.com/node/30640579